Literature DB >> 1361652

1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults.

.   

Abstract

CDC has revised the classification system for HIV infection to emphasize the clinical importance of the CD4+ T-lymphocyte count in the categorization of HIV-related clinical conditions. This classification system replaces the system published by CDC in 1986 (1) and is primarily intended for use in public health practice. Consistent with the 1993 revised classification system, CDC has also expanded the AIDS surveillance case definition to include all HIV-infected persons who have < 200 CD4+ T-lymphocytes/microL, or a CD4+ T-lymphocyte percentage of total lymphocytes of < 14. This expansion includes the addition of three clinical conditions--pulmonary tuberculosis, recurrent pneumonia, and invasive cervical cancer--and retains the 23 clinical conditions in the AIDS surveillance case definition published in 1987 (2); it is to be used by all states for AIDS case reporting effective January 1, 1993.

Entities:  

Mesh:

Year:  1992        PMID: 1361652

Source DB:  PubMed          Journal:  MMWR Recomm Rep        ISSN: 1057-5987


  883 in total

1.  Seroprevalence of HIV, HCV and syphilis in Brazilian prisoners: preponderance of parenteral transmission.

Authors:  E Massad; M Rozman; R S Azevedo; A S Silveira; K Takey; Y I Yamamoto; L Strazza; M M Ferreira; M N Burattini; M N Burattini
Journal:  Eur J Epidemiol       Date:  1999-05       Impact factor: 8.082

2.  Effects of therapy with highly active anti-retroviral therapy (HAART) and IL-2 on CD4+ and CD8+ lymphocyte apoptosis in HIV+ patients.

Authors:  L Caggiari; S Zanussi; M T Bortolin; M D'andrea; G Nasti; C Simonelli; U Tirelli; P De Paoli
Journal:  Clin Exp Immunol       Date:  2000-04       Impact factor: 4.330

3.  Evaluation of TruCount absolute-count tubes for determining CD4 and CD8 cell numbers in human immunodeficiency virus-positive adults. Site Investigators and The NIAID DAIDS New Technologies Evaluation Group.

Authors:  C T Schnizlein-Bick; J Spritzler; C L Wilkening; J K Nicholson; M R O'Gorman
Journal:  Clin Diagn Lab Immunol       Date:  2000-05

Review 4.  Adoption of single-platform technologies for enumeration of absolute T-lymphocyte subsets in peripheral blood.

Authors:  M R O'Gorman; J K Nicholson
Journal:  Clin Diagn Lab Immunol       Date:  2000-05

5.  Anthropometric indices as predictors of survival in AIDS adults. Aquitaine Cohort, France, 1985-1997. Groupe d'Epidémiologie Clinique du Sida en Aquitaine (GECSA).

Authors:  R Thiébaut ; D Malvy; C Marimoutou; F Davis
Journal:  Eur J Epidemiol       Date:  2000       Impact factor: 8.082

6.  Prognostic factors of survival of HIV-infected patients with cytomegalovirus disease: Aquitaine Cohort, 1986-1997. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine (GECSA).

Authors:  C Binquet; F Saillour; N Bernard; M B Rougier; F Leger; F Bonnal; F Dabis
Journal:  Eur J Epidemiol       Date:  2000-05       Impact factor: 8.082

7.  The functional impact of HIV-associated neuropsychological impairment in Spanish-speaking adults: a pilot study.

Authors:  Monica Rivera Mindt; Mariana Cherner; Thomas D Marcotte; David J Moore; Heather Bentley; Maria M Esquivel; Yanira Lopez; Igor Grant; Robert K Heaton
Journal:  J Clin Exp Neuropsychol       Date:  2003-02       Impact factor: 2.475

8.  Lower respiratory tract infections among human immunodeficiency virus-exposed, uninfected infants.

Authors:  Marisa M Mussi-Pinhata; Fabrizio Motta; Laura Freimanis-Hance; Ricardo de Souza; Edgardo Szyld; Regina C M Succi; Celia D C Christie; Maria J Rolon; Mariana Ceriotto; Jennifer S Read
Journal:  Int J Infect Dis       Date:  2010-05-08       Impact factor: 3.623

9.  The impact of age on the prognostic capacity of CD8+ T-cell activation during suppressive antiretroviral therapy.

Authors:  Judith J Lok; Peter W Hunt; Ann C Collier; Constance A Benson; Mallory D Witt; Amneris E Luque; Steven G Deeks; Ronald J Bosch
Journal:  AIDS       Date:  2013-08-24       Impact factor: 4.177

10.  Increase in single-tablet regimen use and associated improvements in adherence-related outcomes in HIV-infected women.

Authors:  David B Hanna; Nancy A Hessol; Elizabeth T Golub; Jennifer M Cocohoba; Mardge H Cohen; Alexandra M Levine; Tracey E Wilson; Mary Young; Kathryn Anastos; Robert C Kaplan
Journal:  J Acquir Immune Defic Syndr       Date:  2014-04-15       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.